Prostate cancer Miniatlas

Prostate carcinoma is the second most common cancer in men worldwide. Certain risk factors have been identified, e.g. age, ethnic group, family history, hormonal levels and certain hormonal influences.

The clinical behaviour of prostate cancer ranges from a well-differentiated microscopic tumour, which may not have a significant clinical relevance, to an aggressive tumour that ultimately leads to metastasis, disease and death.

The frequency of diagnosis has increased due to the widespread use of prostate-specific antigen (PSA) in serum as a screening method.

Symptoms are an unusual presentation in men with prostate cancer and may be difficult to distinguish from symptoms caused by a benign prostate disease.

Diagnosis of prostate cancer is based upon biopsy with guidance of transrectal ultrasound, which should be preceded by measurement of serum PSA.

The Prostate cancer miniatlas is part of an extensive collection of illustrated medical atlases (Miniatlas Collection) covering generic specialties to specific diseases, created to facilitate doctor-patient communication.

If you would like to promote your product using this Miniatlas, please contact us.